AXT Inc. Raises $550 Million After Earnings Hit — Stock Still Up 12%

NEW YORK, April 23 —

AXT Inc. (AXTI) beat Q4 estimates, hit an all-time high, then immediately sold $550mn worth of stock into the rally.

What Actually Happened

AXT makes compound semiconductor substrates, the specialized wafers that go into data center lasers, power electronics, and other components riding the AI infrastructure buildout. Q4 came in above expectations, and the stock ripped 12% to a record.

Then management did something instructive: they filed a $550mn common stock offering and closed it almost immediately. That is not what you do when you think your stock is undervalued. That is what you do when you know the window is open and you want to grab cash before it shuts. The offering closed quickly, which tells you institutional demand was there, but at a discount to the highs.

The B. Riley call is worth parsing. They tripled their price target from $21 to $72, which sounds wildly bullish until you notice the Neutral rating. Translation: the stock already reflects the thesis. The analyst is saying "I see why it's here" not "you should buy it here."

The Catch

The $550mn offering is more than 6x AXT's trailing twelve-month revenue. That is an enormous amount of dilution for a company this size. At 163.2x forward P/E, the market is pricing in a revenue trajectory that would need to roughly double or triple from today's $88mn run rate just to bring the multiple back to earth.

Compound semiconductor demand tied to AI is real. But AXT is a substrate supplier, not a chip designer. Substrate makers are further from the end customer, which means less pricing power and more exposure to inventory cycles. If hyperscaler capex slows even modestly, AXT feels it before Nvidia does.

Bottom Line

Management just told you what they think of the valuation. When a company raises 6x its annual revenue in a single offering days after an all-time high, that is the clearest signal a CEO can send without saying it out loud. The AI substrate story is legitimate, but at 163x forward earnings, you are paying for several years of perfect execution upfront.

Watch what they do with the $550mn. If the next quarter's guidance shows revenue acceleration that justifies deploying that capital, the stock works. If the cash just sits on the balance sheet, you bought the top.

Want a full breakdown of AXT's financials and valuation? Generate a free Basis Report on AXTI.

Basis Report does not hold positions in securities discussed. This is not investment advice.